Wall Street Zen Downgrades Nu Skin Enterprises (NYSE:NUS) to Hold

Nu Skin Enterprises (NYSE:NUS) was downgraded by investment analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a report issued on Saturday.

A number of other equities analysts also recently commented on the company. Zacks Research upgraded Nu Skin Enterprises from a “strong sell” rating to a “hold” rating in a report on Friday, January 30th. Weiss Ratings reissued a “hold (c)” rating on shares of Nu Skin Enterprises in a research report on Thursday, January 22nd. Two research analysts have rated the stock with a Hold rating, According to MarketBeat.com, Nu Skin Enterprises has an average rating of “Hold”.

Nu Skin Enterprises Stock Performance

Shares of NUS stock opened at $8.37 on Friday. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.40 and a current ratio of 2.08. The firm has a market capitalization of $408.09 million, a price-to-earnings ratio of 2.62 and a beta of 1.01. Nu Skin Enterprises has a one year low of $5.32 and a one year high of $14.62. The company has a 50 day moving average price of $10.34 and a 200 day moving average price of $10.68.

Nu Skin Enterprises (NYSE:NUS) last announced its quarterly earnings data on Thursday, February 12th. The company reported $0.29 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.30 by ($0.01). The company had revenue of $370.32 million for the quarter, compared to analysts’ expectations of $382.70 million. Nu Skin Enterprises had a net margin of 10.79% and a return on equity of 8.14%. Nu Skin Enterprises has set its FY 2026 guidance at 0.800-1.200 EPS and its Q1 2026 guidance at 0.100-0.200 EPS. Sell-side analysts anticipate that Nu Skin Enterprises will post 1.05 EPS for the current year.

Institutional Trading of Nu Skin Enterprises

Large investors have recently bought and sold shares of the company. Wedge Capital Management L L P NC lifted its position in shares of Nu Skin Enterprises by 1.1% during the fourth quarter. Wedge Capital Management L L P NC now owns 106,166 shares of the company’s stock worth $1,021,000 after purchasing an additional 1,140 shares in the last quarter. GAMMA Investing LLC increased its stake in Nu Skin Enterprises by 63.5% during the 3rd quarter. GAMMA Investing LLC now owns 3,036 shares of the company’s stock worth $37,000 after buying an additional 1,179 shares during the period. Exchange Traded Concepts LLC lifted its holdings in Nu Skin Enterprises by 8.4% in the 4th quarter. Exchange Traded Concepts LLC now owns 24,739 shares of the company’s stock worth $238,000 after buying an additional 1,912 shares in the last quarter. Wealth Enhancement Advisory Services LLC boosted its position in Nu Skin Enterprises by 13.3% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 22,017 shares of the company’s stock valued at $226,000 after buying an additional 2,587 shares during the last quarter. Finally, Tower Research Capital LLC TRC boosted its position in Nu Skin Enterprises by 107.4% in the 2nd quarter. Tower Research Capital LLC TRC now owns 5,048 shares of the company’s stock valued at $40,000 after buying an additional 2,614 shares during the last quarter. Institutional investors and hedge funds own 82.84% of the company’s stock.

Key Headlines Impacting Nu Skin Enterprises

Here are the key news stories impacting Nu Skin Enterprises this week:

• Positive Sentiment: Board declared a quarterly cash dividend of $0.06 per share (yield ~2.3%), payable Mar. 11 to holders of record Feb. 27 — supports income investors and signals capital-return discipline. Dividend Announcement
• Positive Sentiment: Management is pushing a strategic transformation (including India expansion) and commercial rollout of the Prysm iO device, targeting placement of 100,000 units in 2026 — a potential long-term revenue driver if adoption accelerates. Prysm iO / Strategy Article
• Neutral Sentiment: Company states Q4 and full-year results were within its guidance framework and highlighted >50% growth in 2025 earnings (adjusted), but the positive messaging contrasts with misses vs. external consensus — investors should weigh management framing against external estimates. Business Wire Release
• Neutral Sentiment: Coverage update from Stonegate reiterates reported Q4 numbers (revenue $370.3M; adjusted NI $14.5M; adj EPS $0.29) — a restatement of results rather than a new catalyst. Stonegate Coverage Update
• Negative Sentiment: Q4 results missed consensus: EPS $0.29 vs. $0.30 expected; revenue $370.3M vs. $382.7M expected — revenues fell 16.9% year-over-year with broad declines across key regions, which pressures near-term top-line recovery. Zacks Earnings Miss
• Negative Sentiment: Management cut Q1 and FY2026 guidance meaningfully below consensus — Q1 EPS $0.10–0.20 (street ~$0.29) and FY EPS $0.80–1.20 (street ~$1.42); revenue ranges likewise sit below expectations — the guidance shortfall is the primary driver of the market reaction. Guidance & Press Release
• Negative Sentiment: Analyst and media transcripts reiterate the miss and highlight deteriorating customer counts (paid affiliates down ~10%) and margin pressures; near-term fundamentals appear weaker than the market had modeled. Earnings Call Transcript

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc is a Utah-based direct selling company that develops and distributes personal care products and dietary supplements. Operating through a network marketing model, Nu Skin offers a portfolio of wellness, anti-aging skin care, hair care and nutritional products designed to support healthy living and appearance. The company leverages independent distributors to market its offerings directly to consumers across multiple channels, including online platforms and localized events.

Founded in 1984 by Blake M.